Like some aspects of reproductive function, menopausal symptoms appear to exhibit seasonal variation, according to new research from Menopause.
Hormonal therapy is not without controversy but it is still one of the most effective treatments for patients with symptoms.
Women who reach menopause before age 40 may have an increased risk for subsequent cardiovascular disease, according to research from JAMA.
New research has found that the role of hormone therapy (HT) in menopausal patients with breast cancer and gynecologic malignancies is a mixed bag.
Research from the American Journal of Obstetrics & Gynecology indicates that menopausal white women gain significantly more abdominal fat than black women, potentially increasing their risk of type 2 diabetes and CVD.
Menopausal women with frequent night sweats have more sleep, but that may not be a plus for brain function, according to a study presented at The North American Menopause Society (NAMS) Annual Meeting in Chicago in September.
Although nearly half of postmenopausal women reported having vulvovaginal symptoms (VVS), only a minority discussed their symptoms during a well-woman visit with a primary care provider or gynecologist, according to recent survey analysis.
A new study, which found that women with premature and early menopause were at increased risk of having a non-fatal cardiovascular disease event before age 60, has consequential public health and clinical implications.
A recent study describes the development of a web-based calculator that predicts the likelihood of experiencing multiple and competing morbidity outcomes over 5, 10, and 15 years.